These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27478784)

  • 61. Gradation of microcapsule wall porosity by deposition of polymer mixtures (Eudragit RL and Eudragit RS). Phase separation of polymer mixtures and effects of external media and conditions on release.
    Donbrow M; Hoffman A; Benita S
    J Microencapsul; 1995; 12(3):273-85. PubMed ID: 7650592
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D; Kleinebudde P
    Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Guar gum/ethylcellulose coated pellets for colon-specific drug delivery.
    Ji CM; Xu HN; Sun NY; Lu YP; Wu W
    Yao Xue Xue Bao; 2007 Jun; 42(6):656-62. PubMed ID: 17702405
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of film composition and various penetration enhancers concentrations on prazosin release from acrylic polymeric films.
    Hosny EA; Abdel Hady SS; Niazy EM
    Pharm Acta Helv; 1998 Jan; 72(5):247-54. PubMed ID: 9540456
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prolonged-release minitablets with carbamazepine - preliminary observations in vitro.
    Dzajkowska M; Hanna K; Anna M; Maja S; Dagmara D; Anna S; Malgorzata S
    J Pharm Pharmacol; 2017 Apr; 69(4):471-479. PubMed ID: 28000299
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Investigation of a new pH-responsive nanoparticulate pore former for controlled release enteric coating with improved processability and stability.
    Chen K; Chang HHR; Shalviri A; Li J; Lugtu-Pe JA; Kane A; Wu XY
    Eur J Pharm Biopharm; 2017 Nov; 120():116-125. PubMed ID: 28887098
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development of terbutaline sulfate sustained-release coated pellets.
    Umprayn K; Chitropas P; Amarekajorn S
    Drug Dev Ind Pharm; 1999 Apr; 25(4):477-91. PubMed ID: 10194603
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release.
    Wulff R; Leopold CS
    Int J Pharm; 2014 Dec; 476(1-2):78-87. PubMed ID: 25239771
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Effect of EUDRAGIT® RS on the release behaviour of theophylline solid dispersions].
    Orugun O; Oyi A; Olowosulu A; Apeji Y; Olayemi O
    Ceska Slov Farm; 2016; 65(6):226-231. PubMed ID: 28079388
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Formulation and evaluation of multiparticulate system for chronotherapeutic delivery of salbutamol sulphate.
    Chaudhari PM; Chaudhari PD
    J Pharm Bioallied Sci; 2012 Mar; 4(Suppl 1):S71-3. PubMed ID: 23066213
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combination of Pectin and Eudargit RS and Eudragit RL in the Matrix of Pellets Prepared by Extrusion-Spheronization for Possible Colonic Delivery of 5-Amino Salicylic Acid.
    Akhgari A; Abbaspour M; Moradkhanizadeh M
    Jundishapur J Nat Pharm Prod; 2013; 8(2):86-92. PubMed ID: 24624194
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Study of in vitro and in vivo dissolution of theophylline from film-coated pellets.
    Muskó Z; Pintye-Hódi K; Gáspár R; Pintye J; Szabó-Révész P; Eros I; Falkay G
    Eur J Pharm Biopharm; 2001 Mar; 51(2):143-6. PubMed ID: 11226821
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multiple response optimisation of processing and formulation parameters of pH sensitive sustained release pellets of capecitabine for targeting colon.
    Pandey S; Swamy SMV; Gupta A; Koli A; Patel S; Maulvi F; Vyas B
    J Microencapsul; 2018 May; 35(3):259-271. PubMed ID: 29659317
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relationship of film properties to drug release from monolithic films containing adjuvants.
    Jenquin MR; Sarabia RE; Liebowitz SM; McGinity JW
    J Pharm Sci; 1992 Oct; 81(10):983-9. PubMed ID: 1432624
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Formulation and evaluation of sustained release enteric-coated pellets of budesonide for intestinal delivery.
    Raval MK; Ramani RV; Sheth NR
    Int J Pharm Investig; 2013 Oct; 3(4):203-11. PubMed ID: 24350040
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lactic acid-induced modifications in films of Eudragit RL and RS aqueous dispersions.
    Omari DM; Sallam A; Abd-Elbary A; El-Samaligy M
    Int J Pharm; 2004 Apr; 274(1-2):85-96. PubMed ID: 15072785
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preparation and stability investigation of tamsulosin hydrochloride sustained release pellets containing acrylic resin polymers with two different techniques.
    Fan R; Sun Y; Li B; Yang R; Ma W; Sun J
    Asian J Pharm Sci; 2017 Mar; 12(2):193-201. PubMed ID: 32104330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.